Indaptus Therapeutics, Inc. (INDP) News
Track canonical SquawkNews coverage tagged to INDP, Indaptus Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 8 indexed stories across 8 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
MRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even Better
Moderna, Inc. (MRNA) is on track to become September’s second-best performer in the S&P 500, but five smaller stocks have delivered even larger gains this month, driven by developments ranging from an impending ALS trial
EQUITY | Sep 25, 2026, 03:24 AM UTC
H
Radiant Logistics, Waystar, Forgent Power Solutions And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones index falling around 300 points on Tuesday. Shares of Radiant Logistics Inc (NYSE: RLGT ) rose sharply after the company reported better-than-expected fourth-quarter financial r
LIVE | Sep 15, 2026, 01:53 PM UTC
M
Indaptus Therapeutics raises about $24.0 million in private placement
Indaptus Therapeutics entered a stock purchase agreement for a private placement of 20,338,974 common shares, expected to generate about $24.0 million in gross proceeds. Shares are priced at the Nasdaq Minimum Price plus
EQUITY | Sep 10, 2026, 10:13 AM UTC
L
Indaptus board member Tim Ruan resigns effective immediately
Indaptus Therapeutics director Tim Ruan resigned from the board, effective immediately.
REGULATION | Sep 04, 2026, 08:15 PM UTC
L
Indaptus Therapeutics launches $100 million ATM equity program
Indaptus Therapeutics entered an amended and restated at-the-market offering agreement for flexible equity access, allowing sales of up to $100 million of common stock. H.C. Wainwright acts as sales agent and potentially
EQUITY | Sep 01, 2026, 11:34 AM UTC
L
BXP prices $700 million senior unsecured notes offering
BXP prices a $700 million offering of senior unsecured notes, according to the wire item.
MNA | Aug 18, 2026, 09:14 AM UTC
L
Indaptus Therapeutics reports Q2 2026 results; issues corporate update
Indaptus Therapeutics (INDP) reports its second quarter 2026 financial results and provides a corporate update, according to TradeXchange Newsdesk.
EARNINGS | Aug 13, 2026, 11:00 AM UTC
M
INDP Sells 20M Shares
Indaptus Therapeutics enters stock sale agreement to sell 20M shares for $0.06/share, expecting $12M in gross proceeds
EQUITY | Jun 24, 2026, 08:07 PM UTC